CRIS Current Research Information System

CAMPANA, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 10.820
NA - Nord America 10.093
EU - Europa 6.028
SA - Sud America 606
AF - Africa 510
Continente sconosciuto - Info sul continente non disponibili 493
OC - Oceania 10
Totale 28.560
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.909
VN - Vietnam 3.352
SG - Singapore 2.606
CN - Cina 2.571
GB - Regno Unito 1.538
IT - Italia 972
DE - Germania 784
HK - Hong Kong 703
SE - Svezia 621
BR - Brasile 442
FR - Francia 439
IN - India 432
RU - Federazione Russa 335
BD - Bangladesh 330
UA - Ucraina 289
KR - Corea 251
IE - Irlanda 229
FI - Finlandia 156
NL - Olanda 156
JP - Giappone 155
CH - Svizzera 139
ZA - Sudafrica 135
TG - Togo 104
CI - Costa d'Avorio 103
EE - Estonia 94
CA - Canada 88
AR - Argentina 77
SC - Seychelles 69
ID - Indonesia 51
PH - Filippine 50
JO - Giordania 48
MX - Messico 46
BE - Belgio 44
IQ - Iraq 44
NG - Nigeria 44
TH - Thailandia 42
TR - Turchia 38
AT - Austria 37
PL - Polonia 37
BG - Bulgaria 36
TW - Taiwan 30
EC - Ecuador 23
PK - Pakistan 20
ES - Italia 18
IR - Iran 18
CL - Cile 16
GR - Grecia 16
MA - Marocco 16
CO - Colombia 15
SA - Arabia Saudita 15
HR - Croazia 13
LT - Lituania 12
UZ - Uzbekistan 12
AU - Australia 10
CZ - Repubblica Ceca 10
JM - Giamaica 10
PE - Perù 10
EG - Egitto 9
RO - Romania 9
CR - Costa Rica 8
HU - Ungheria 8
LB - Libano 8
PY - Paraguay 8
AL - Albania 7
AE - Emirati Arabi Uniti 6
MY - Malesia 6
PT - Portogallo 6
DO - Repubblica Dominicana 5
DZ - Algeria 5
GT - Guatemala 5
MD - Moldavia 5
NP - Nepal 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
DK - Danimarca 4
IL - Israele 4
KZ - Kazakistan 4
NI - Nicaragua 4
PR - Porto Rico 4
SN - Senegal 4
UY - Uruguay 4
VE - Venezuela 4
GY - Guiana 3
KE - Kenya 3
KG - Kirghizistan 3
KW - Kuwait 3
SK - Slovacchia (Repubblica Slovacca) 3
AO - Angola 2
AZ - Azerbaigian 2
BO - Bolivia 2
BS - Bahamas 2
CY - Cipro 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
LU - Lussemburgo 2
MK - Macedonia 2
QA - Qatar 2
SI - Slovenia 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 28.043
Salva come PNG Salva come JPEG
Città #
Singapore 1.771
Southend 1.341
Ashburn 1.071
Fairfield 859
Ho Chi Minh City 781
San Jose 684
Hong Kong 670
Hanoi 661
Chandler 624
Hefei 534
Santa Clara 429
Seattle 390
Woodbridge 389
Houston 368
Wilmington 345
Princeton 316
Beijing 301
Cambridge 287
Dong Ket 262
Boardman 232
Seoul 228
Dublin 224
Ann Arbor 203
Los Angeles 192
Lauterbourg 187
Jacksonville 178
Bologna 170
New York 149
Council Bluffs 141
Tokyo 129
Helsinki 126
Bern 125
Da Nang 117
Westminster 114
Milan 110
Lomé 104
Abidjan 103
Nanjing 102
Dallas 101
Padova 96
Berlin 94
Buffalo 88
Haiphong 86
Redondo Beach 71
São Paulo 71
Frankfurt am Main 70
Shanghai 65
Jinan 61
Guangzhou 59
Shenyang 56
Tianjin 52
Saint Petersburg 51
Bengaluru 50
San Diego 50
Changsha 49
Chicago 49
Nanchang 49
Amman 47
Abeokuta 42
Biên Hòa 42
Hải Dương 42
Medford 42
Munich 41
Des Moines 40
Can Tho 36
Redmond 36
Mülheim 35
Turin 35
Sofia 34
Florence 33
Quận Bình Thạnh 33
Atlanta 32
Ha Long 31
Jakarta 30
Phoenix 30
Bremen 29
Brussels 29
Ninh Bình 29
Rome 29
London 28
Hebei 27
San Francisco 27
Johannesburg 26
Wuhan 26
Yubileyny 26
Zhengzhou 26
Bắc Giang 24
Tongling 24
Amsterdam 23
Hangzhou 23
Nuremberg 23
Toronto 23
Warsaw 23
Brooklyn 22
Orem 22
Thái Nguyên 22
Bắc Ninh 21
Fuzhou 21
Lappeenranta 21
Washington 21
Totale 17.561
Salva come PNG Salva come JPEG
Nome #
Metastatic 5-mm rectal neuroendocrine carcinoma. 633
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms 400
Radiomic analysis performed on 68Ga-DOTANOC PET/CT allows discriminating primary pancreatic neuroendocrine tumour grading 301
A [68Ga]Ga-DOTANOC PET/CT radiomic model for non-invasive prediction of tumour grade in pancreatic neuroendocrine tumours 271
MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer 263
Merkel Cell Carcinoma: An Updated Review Focused on Bone and Bone Marrow Metastases 251
Comparing PET-derived semiquantitative parameters and radiomic features in discriminating G1 and G2 primary pancreatic neuroendocrine tumours in 68Ga-DOTANOC PET/CT 239
Basis for treatment of functioning neuroendocrine tumours. 235
Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis 234
(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. 226
Chromogranin A: is it a useful marker of neuroendocrine tumors? 225
Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study 224
Adult coeliac disease diagnosed by endoscopic biopsies in the duodenal bulb. 223
68Ga-DOTANOC PET/CT Detects Multifocal Hepatocellular Carcinoma 223
Endocrine pancreatic tumors: factors correlated with survival. 222
Chronic asymptomatic pancreatic hyperenzymemia is a benign condition in only half of the cases: a prospective study 219
A case of primary pancreatic lymphoma. 217
WHO 2010 classification of pancreatic endocrine tumors. Is the new always better than the old? 213
Is surgery the best treatment for sporadic small (≤2 cm) non-functioning pancreatic neuroendocrine tumours? A single centre experience 213
The ELISA fecal elastase-1 polyclonal assay reacts with different antigens than those of the monoclonal assay. 210
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors. 204
Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review 200
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study 199
68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET. 197
Are There Prognostic Factors Related to Recurrence in Pancreatic Endocrine tumors? 196
18f-fdg pet/ct for restaging gastric cancer after surgical resection 195
Radiomic analysis could allow detecting misassigned bioptic grading when discriminating G1 and G2 primary pancreatic neuroendocrine tumours imaged with 68Ga-DOTANOC PET/CT 195
Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid. 193
Appendiceal goblet cell carcinoma has marginal advantages from perioperative chemotherapy: a population-based study with an entropy balancing analysis 192
Comparison between (68)Ga-DOTA-NOC and (18)F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. 191
G1/G2 discrimination of pNET with [68Ga]Ga-DOTANOC PET/CT quantitative parameters: is it feasible? 190
Endocrine tumors of the ileum: factors correlated with survival. 189
Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors 188
The role of lymph node ratio in recurrence after curative surgery for pancreatic endocrine tumours. 188
Pancreatic involvement in systemic sarcoidosis. A case report. 187
Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study 187
A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience 187
Incidental diagnosis of very small rectal neuroendocrine neoplasms: when should endoscopic submucosal dissection be performed? A single ENETS centre experience 185
68Ga-DOTA-NOC PET/CT detects somatostatin receptors expression in von hippel-lindau cerebellar disease. 184
Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome. 181
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors 179
Zollinger-Ellison syndrome. Diagnosis and therapy. 178
Treatment of advanced gastro‐entero‐pancreatic neuro‐ endocrine tumors: A systematic review and network meta‐analysis of phase iii randomized controlled trials 177
Medical treatment of endocrine gastroenteropancreatic tumors. 176
Efficacy and Cost-Effectiveness of Immediate Surgery versus a Wait-and-See Strategy for Sporadic Nonfunctioning T1 Pancreatic Endocrine Neoplasms. 176
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors 175
Water-related techniques in colonoscopy: the end justifies the means! 175
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy? 175
Endoscopic Ultrasound-Guided Locoregional Treatments for Pancreatic Neuroendocrine Neoplasms 172
[68Ga]Ga-DOTANOC Uptake at Pancreatic Head/Uncinate Process: Is It a Persistent Diagnostic Pitfall Over Time? 172
Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis. 170
Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 Patients 169
Is radical surgery always curative in pancreatic neuroendocrine tumors? A cure model survival analysis 168
Siblings Diagnosed With Primary Neuroendocrine Tumor of the Left Hepatic Duct 166
Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study 165
Classic versus innovative strategies for immuno-therapy in pancreatic cancer 164
Sedation during colonoscopy and the benefits of lubrication 164
68Ga DOTANOC PET/CT Detects Primary Malignant Insulinoma. 164
An Update on Appendiceal Neuroendocrine Tumors 161
Pancreatic endocrine tumors less than 4 cm in diameter: resect or enucleate? a single-center experience. 161
Validation of the 2010 WHO classification and a new prognostic proposal: A single centre retrospective study of well-differentiated pancreatic neuroendocrine tumours 160
Patient-reported outcomes in patients with endocrine tumors of the Ileum 159
Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study 158
Lubrication during colonoscopy: a forgotten factor. 158
18F-Fluorodeoxyglucose Uptake in PDGFRA-Mutant Gastrointestinal Stromal Tumors 158
Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors. 157
Multiple gastrinomas of the duodenum in a patient with sporadic Zollinger-Ellison syndrome. 154
Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis 154
Assessment of the quality of life in chronic pancreatitis using Sf-12 and EORTC Qlq-C30 questionnaires. 152
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study 152
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence. 152
Radiomic Model Discriminating Low Grade Pancreatic Neuroendocrine Tumours Assessed by Biopsy of the Primary Lesion 151
Warm water and oil assistance in colonoscopy 151
Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs 151
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort 150
Long-term survival in neuroendocrine tumors of the pancreas. 150
Evaluation of patient-reported outcome in subjects treated medically for acute pancreatitis: a follow-up study 150
Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible? 147
Multiple gastric endocrine tumors and gastrinomas of the duodenum in a patient with a ZES MEN I 146
WHO-2010 and WHO-2000 classifications for pancreatic endocrine tumors. Is it time to change ? 146
Maffucci syndrome with hemangioma of the liver 146
Patient-reported outcomes in subjects with neuroendocrine tumors of the pancreas. 146
[68Ga]Ga-DOTANOC PETICT & radiomics: Potential role in discriminating tumor grade in well-differentiated primary pancreatic neuroendocrine tumors 146
Warm water and oil for the difficult colon 145
Warm water or oil-assisted colonoscopy: toward simpler examinations? 144
Sedation on demand and lubrication during colonoscopy: should we change our mind ? 144
Treatment of Zollinger-Ellison Syndrome 144
[177Lu]Lu-DOTA-TATE versus standard of care in adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): a cost-consequence analysis from an Italian hospital perspective 144
Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations 142
Lutetium [177Lu]-DOTA-TATE in gastroenteropancreatic-neuroendocrine tumours: rationale, design and baseline characteristics of the Italian prospective observational (REAL-LU) study 141
[68Ga]Ga-DOTANOC PET/CT Derived Radiomic Features Can Discriminate Pancreatic Neuroendocrine Tumours from Accessory Spleens: Preliminary Results 141
Autoimmune pancreatitis: the classification puzzle. 140
Sporadic Small (≤20 mm) Nonfunctioning Pancreatic Neuroendocrine Neoplasm: is the Risk of Malignancy Negligible When Adopting a More Conservative Strategy? A Systematic Review and Meta-analysis 140
Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor 140
Quality of life in chronic pancreatitis. 139
The surgical treatment of neuroendocrine pancreatoduodenal tumors in multiple endocrine neoplasia type 1 139
Lymph Node Ratio as a Prognostic Factor in Patients with Pancreatic Endocrine Tumours JOP 139
Landscape and future perspectives of immunotherapy in neuroendocrine neoplasia 137
Value of both WHO and TNM classification systems for patients with pancreatic endocrine tumors: results of a single-center series. 136
Is 68Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour? 136
Totale 18.362
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.225
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.525 0 83 148 174 238 131 50 216 117 132 833 403
2022/20233.048 296 400 131 351 234 245 95 181 530 97 242 246
2023/2024844 87 151 72 78 71 175 39 47 23 32 31 38
2024/20253.934 154 555 347 264 649 221 301 113 59 257 207 807
2025/202611.406 1.087 1.619 885 762 1.023 502 1.115 535 1.979 806 642 451
2026/2027382 361 21 0 0 0 0 0 0 0 0 0 0
Totale 28.560